VA seeks NGS malignancy testing services for cancer patients.
The Department of Veterans Affairs, Network Contract Office 10, is seeking sources for Next Generation Sequencing (NGS) malignancy testing services. The procurement aims to provide comprehensive genomic profiling for cancer patients at the VA facility in Indianapolis, Indiana. The testing must include DNA and RNA sequencing to identify actionable mutations, with results reported in a clinical context. Vendors must demonstrate experience with CLIA-certified laboratories and ability to handle VA-specific data security requirements. The contract is expected to cover a base period with options, though exact duration and value are not specified.